Susquehanna International Group, LLP Vir Biotechnology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$7.26 - $10.7 $528,528 - $778,960	-72,800 Reduced 74.9%	24,400 $182,000
Q2 2024 Aug 15, 2024	SELL	$7.63 - $12.66 $116,739 - $193,698	-15,300 Reduced 13.6%	97,200 $865,000
Q1 2024 May 07, 2024	BUY	$8.6 - $11.9 $559,860 - $774,690	65,100 Added 137.34%	112,500 $1.14 Million
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $24,056 - $31,898	-3,100 Reduced 6.14%	47,400 $476,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $24.62 $1.36 Million - $3.67 Million	-149,200 Reduced 74.71%	50,500 $473,000
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $531,280 - $624,941	22,900 Added 12.95%	199,700 $4.9 Million
Q1 2023 May 16, 2023	BUY	$22.26 - $30.85 $2.57 Million - $3.56 Million	115,300 Added 187.48%	176,800 $4.11 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $11,976 - $16,932	600 Added 0.99%	61,500 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $978,736 - $1.67 Million	-53,600 Reduced 46.81%	60,900 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $442,655 - $619,440	23,200 Added 25.41%	114,500 $2.92 Million
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $1.93 Million - $3.65 Million	-91,200 Reduced 49.97%	91,300 $2.35 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $687,534 - $1.2 Million	22,200 Added 13.85%	182,500 $7.64 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $2.36 Million - $3.68 Million	-67,500 Reduced 29.63%	160,300 $6.98 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $751,750 - $989,400	19,400 Added 9.31%	227,800 $10.8 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $3.34 Million - $10.5 Million	126,800 Added 155.39%	208,400 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $719,382 - $1.22 Million	28,200 Added 52.81%	81,600 $2.19 Million
Q3 2020 Nov 16, 2020	SELL	$28.28 - $53.6 $2.01 Million - $3.82 Million	-71,200 Reduced 57.14%	53,400 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $3.17 Million - $5.45 Million	113,800 Added 1053.7%	124,600 $5.11 Million
Q1 2020 May 15, 2020	BUY	$12.04 - $60.2 $130,031 - $650,160	10,800 New	10,800 $370,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$123 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$121 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$96.9 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$41.5 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$26.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $979M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account